A Phase I/II Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
This is a two-part, open-label, Phase I/II study in subjects with relapsed or refractory TdT-positive leukemia for which no standard therapies are expected to result in durable remission.
100 Clinical Results associated with OncoVista, Inc.
0 Patents (Medical) associated with OncoVista, Inc.
100 Deals associated with OncoVista, Inc.
100 Translational Medicine associated with OncoVista, Inc.